About us
Protecting our tomorrow
A firm focus on vaccines stands at the core of everything we do.
READ MORE
Our strategy
Our Leadership Team
Governance
Business Ethics
Sustainability
What we do
From R&D to manufacturing
We are focused on the research, development and manufacturing of innovative life-saving vaccines
READ MORE
Products
Pipeline
INVESTORS
Investors
We are committed to providing our shareholders and the media with reliable and transparent information about our business, development programs and results in an open and timely manner
Read more
Annual Report 2023
News
Events & Presentations
Financials
Stock information
Analysts
Annual General Meeting
Shareholder Portal
FAQ
Careers
Careers
We offer a challenging international working environment in which job satisfaction and personal growth have a high priority.
READ MORE
Working With Us
Job Openings
Our Employees

Ownership

Last updated: May 2024.

No. of registered shareholders	Approx. 120,000
Distribution of share capital	Denmark: 69% EU, other: 12% North America: 10% Non-registered: 9%
Largest shareholders	ATP, Denmark (> 10 %)
Holding of own shares	0.37% *
* To hedge obligations under incentive schemes for the Company's executive management and board of directors, Bavarian Nordic has repurchased 288,222 shares as of May 2024.